Candriam Equities L Oncology Impact, V - Capitalisation/ LU2425425506 /
| NAV2024-05-16 | Chg.-1.0800 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 1,857.8800GBP | -0.06% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | - | - | 6.68 | -1.24 | -1.68 | 3.85 | 4.18 | 1.33 | -0.64 | 3.81 | 2.58 | -4.38 | - |
| 2023 | -0.16 | -2.24 | -0.70 | 1.18 | -1.15 | -2.41 | -0.29 | -0.49 | -1.60 | -5.78 | 4.71 | 5.03 | -4.28% |
| 2024 | 1.50 | 4.87 | 1.65 | -2.50 | 3.81 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 11.12% | 11.10% | 11.58% | -% | -% |
| Sharpe ratio | 2.16 | 3.04 | 0.20 | - | - |
| Best month | +5.03% | +5.03% | +5.03% | +6.68% | - |
| Worst month | -2.50% | -2.50% | -5.78% | -5.78% | - |
| Maximum loss | -4.94% | -4.94% | -13.88% | - | - |
| Outperformance | - | - | - | - | - |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,400.9099 | +7.62% | +6.05% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,565.5000 | +7.75% | +6.45% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.9700 | +4.02% | -4.87% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,252.5000 | +5.81% | +17.09% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,611.3000 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.4500 | +6.23% | +14.09% | |
| Candriam Equities L Oncology Imp... | paying dividend | 236.2900 | +6.27% | +2.13% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.3300 | +7.17% | +4.73% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,796.0000 | +3.23% | +2.32% | |
| Candriam Equities L Oncology Imp... | reinvestment | 159.3600 | +5.69% | +16.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,114.3201 | +5.00% | -2.15% | |
| Candriam Equities L Oncology Imp... | reinvestment | 260.0600 | +7.14% | +17.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.4600 | +3.60% | -5.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.8900 | +7.16% | +4.72% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.1900 | +4.88% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,857.8800 | +6.15% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,884.1399 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.8100 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 274.5300 | +6.26% | +2.11% |
Performance
| YTD | +9.51% | ||
|---|---|---|---|
| 6 Months | +17.11% | ||
| 1 Year | +6.15% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +24.49% | ||
| Year | |||
| 2023 | -4.28% | ||
